From Ozempic to Mounjaro

Disclaimer: Please ensure you chat with your care provider before making any changes. They are going to support you to do it as safely as possible.  

With Ozempic in high demand and little to none to go around, and Mounjaro entering the market here in Canada, some or many of you may be considering switching from one to the other. 

Ozempic and Mounjaro are the main drugs on the market for both diabetes and obesity management. But is their dosing the same? Can you just switch without considering anything at all? (Hint: don’t do that.)

Let’s get into it. 

Related weight loss medication videos: 

▪️ Mounjaro is coming to Canada: https://youtu.be/pvIZK7pu27Q 

▪️ Ozempic Alternatives: https://youtu.be/8zsjXu8kLs4 

▪️ Muscle Loss with Ozempic, Wegovy & Mounjaro: https://youtu.be/lnEH-v64aG0 

– 

Live in Alberta? Come see me at my Pharmacist-led Obesity Clinic at Apothecare Pharmacy – http://apothecarerx.ca 

Products to support your weight loss journey: 

USA: https://amzn.to/3RC7MSd

Canada: https://amzn.to/45gq4vg

– 

Sign up for my newsletter: http://eepurl.com/gdB2qn 

– 

Have questions or need support on your weight-loss journey? Book a consultation with me: https://calendly.com/drdanconsult/he

Dr. Dan

Follow me on social media for regular updates – @TheOfficialDrDan

Subscribe to my newsletter for a heads-up on all new content.

Sharing is caring! Here’s the social, email, and even text link – https://healthevolved.co/ozempic-to-mounjaro

If you need some coaching support on your weight management journey, you can book a consultation with me to see if you’d be a good fit for our program. 

Questions or comments? Please send them my way on our Contact Us page!

Share:

More Posts

The Ozempic Pill Has a Ceiling — New Trial Proves It

New clinical trial data on orforglipron reveals a biological ceiling that every person on GLP-1 medications needs to understand. I’m breaking down the ATTAIN-MAINTAIN trial findings, explaining what the 15% threshold means for long-term weight management, and identifying exactly who is — and isn’t — a strong candidate for the transition to the Ozempic pill.

Reducing Your Zebound Dose Could Undo ALL Your Progress

The SURMOUNT MAINTAIN trial has delivered the most compelling evidence yet that obesity requires long-term management — not a finish line. New data reveals exactly what happens to your results at every dose decision, and the numbers make the choice undeniable.

The Retatrutide Paradox: Why This “Triple Threat” Works

Retatrutide is a triple-action therapy targeting GLP-1, GIP, and glucagon receptors simultaneously — a fundamentally different design from current treatments. Early clinical data reveals significant liver-fat reductions and an unexpected paradox: a receptor long assumed to raise blood sugar instead helps mobilize stored fat and support resting metabolism.

Retatrutide TRIUMPH-1 Results: 28% Weight Loss

TRIUMPH-1 Phase 3 trial data reveals retatrutide achieved up to 30% body weight loss — outperforming bariatric surgery benchmarks without a single incision. I’m breaking down the full efficacy numbers, safety signals, and what this triple-hormone agonist means for your weight management options right now.

Send Us A Message

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.